Previous 10 | Next 10 |
BioElectronics (OTCPK:BIEL), an electroceutical company, has added two additional international distribution partners to its portfolio. The first new order comes from Stada MENA, which will be distributing BioElectronics' ActiPatch in Bahrain and the Kingdom of Saudi Arabia. The second order ...
FREDERICK, MD - ( NewMediaWire ) - February 28, 2022 - BioElectronics Corporation ( https://www.bielcorp.com/ OTC: BIEL) is pleased to update, in a letter from its Chairman, Richard Staelin, Ph.D., new distribution partners, personnel changes, and new clinical research studies. SALES...
FREDERICK, MD, Jan. 03, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioElectronics Corporation (OTC PINK:BIEL) is pleased to announce that the managers of the firm’s two largest lenders, Ibex LLC and St. John’s LLC, both of which are controlled by Whelan family m...
BioElectronics Corporation (OTCPK:BIEL): Keeping in line with BIEL’s impressive year-over-year growth, the nine months ended September 30, 2021 sales were 463% higher than the same period during 2020. Additionally, Deferred revenue amounted to $256,398 at the quarter’s close; th...
Year over Year Revenue Growth Exceeds 463% FREDERICK, MARYLAND - ( NewMediaWire ) - November 16, 2021 - BioElectronics Corporation ( https://www.bielcorp.com/ OTC: BIEL) announces a 463% increase in sales revenue resulting in a profitable 3 rd quarter. Keeping in ...
Frederick, MD - ( NewMediaWire ) - October 07, 2021 - BioElectronics Corporation (OTC: BIEL), a leader in the development and manufacturing of non-invasive electroceuticals, today announced that Sree Koneru, Ph.D., will present at the Pain Management Investor F orum to be held (virtua...
“No pain, no gain” is a motivational gym saying used for years. Investors have found the saying also applies to portfolio gains. The pain management industry is rapidly growing and now provides an even broader spectrum of publicly traded opportunities. Why? Reduced opioid use has...
NobleCon Online Investor Event - New Developments in Pain Management - October 7, 2021 Exclusively on Channelchek - Featuring Baudax Bio (BXRX), BioElectronics Corporation (BIEL), Heron Therapeutics (HRTX), MedX Health (MDXHF), NanoVibronix (NAOV), Virpax Pharmaceuticals (VRPX) Read More >...
BioElectronics (OTCPK:BIEL +26.7%) lays out Q2 financials: Keeping in line with company’s impressive Y/Y growth, the six months ended June 30, 2021 sales were 665% higher than the same period during 2020. While Q2 2021 sales were lower than Q1 2021 sales, this does not account for...
Revenue Growth Exceeds 665% FREDERICK, MARYLAND - ( NewMediaWire ) - August 30, 2021 - BioElectronics Corporation ( https://www.bielcorp.com/ OTC: BIEL) said today that it would like to clarify information about the Company and acknowledge the investor community’s request for ...
News, Short Squeeze, Breakout and More Instantly...
96% of the Dogs Treated With the Active Model 088 Device Showed Marked Improvement FREDERICK, MD, March 25, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioElectronics Corporation ( https://www.bielcorp.com/ OTC: BIEL) a developer of medical technology products, announces the ...
Beneficial Treatment Effect for Phantom and Residual Limb Pain Identified FREDERICK, MD - ( NewMediaWire ) - February 23, 2024 - BioElectronics Corporation ( https://www.bielcorp.com/ OTC: BIEL a developer of medical technology products, today announces the publication of ...
Discusses Clinical Trial Progress and Potential Legal Action Against MundiPharma FREDERICK, MD - ( NewMediaWire ) - February 15, 2024 - BioElectronics Corporation ( https://www.bielcorp.com/ OTC: BIEL a developer of medical technology products, today releases an update ...